With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...
Following publication (Goubar et al 2008) MPES methods were used to generate the official UK statistics on HIV prevalence, published by the Department of Health or the Health Protection Agency. A ...
Following publication (Goubar et al 2008) MPES methods were used to generate the official UK statistics on HIV prevalence, published by the Department of Health or the Health Protection Agency. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback